Untersuchungen zur Behandlung der zerebrospinalen Nematodiasis bei Ziegen

Translated title of the contribution: Therapeutical outcome of cerebrospinal nematodiasis in goats

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


In 17 goats the therapeutical outcome of cerebrospinal nematodiasis, a parasitic infection in the central nervous system with the nematode Elaphostrongylus cervi, is described. The diagnosis was made on the basis of physical findings and cerebrospinal fluid eosinophilia. The therapy was based on the administration of a non-steroidal antiinflammatory drug (flunixin meglumine) and two anthelmintics (fenbendazol, ivermectin) for five days. The response to therapy was documented immediately and 30 days after therapy and by owners report up to 30 months. Eleven goats (64.7 %) showed an improvement of the neurological signs directly after therapy. Three had a complete recovery. Signs of a light and middle ataxie were still present in 6 and 2 goats, respectively. Six recumbent goats (35.3 %) had to be euthanasied because of a non-therapeutical response. This study has shown a clinical impression of successful use of flunixin meglumine, fenbendazole and ivermectin in goats with light to middle neurological signs. The goats could accommodate the remaining ataxia without showing a reduced production. Goats with high neurological deficits could not be successful treated based on the high degree of the neurological damage.

Translated title of the contributionTherapeutical outcome of cerebrospinal nematodiasis in goats
Original languageGerman
Pages (from-to)22-24
Number of pages3
JournalDeutsche Tierarztliche Wochenschrift
Issue number1
StatePublished - 1999
Externally publishedYes


  • Cerebrospinal nematodiasis
  • Elaphostrongylus cervi
  • Goats
  • Therapy454-455

ASJC Scopus subject areas

  • veterinary(all)


Dive into the research topics of 'Therapeutical outcome of cerebrospinal nematodiasis in goats'. Together they form a unique fingerprint.

Cite this